Kolabtreeを選ぶ理由

開始はすばやく簡単です。初期費用はかかりません。

サービス依頼と専門家への見積依頼は無料です。

Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。

専門家と直接連携し、必要な成果を正しく得られます。

専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。

Shweta K. に連絡

連絡する

Kolabtreeを選ぶ理由

この専門家をプロジェクトに採用したいですか？見積もりを依頼無料で。

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Shweta K.に依頼

India

Precision Oncology & Biomarker Strategy Consultant | Senior Director | Computational Biology | NGS & Multi-Omics | Trans

プロフィール概要

Senior Director and precision oncology consultant with 19 years of experience in computational biology, biomarker strategy, and AI-enabled translational research. I help pharmaceutical companies, biotech organizations, and research teams translate complex genomic, transcriptomic, and multi-omics data into actionable scientific insights that support drug development decisions.
My work spans biomarker discovery and patient stratification across 50+ oncology indications including NSCLC, AML, MDS, GBM, CRC, and immuno-oncology programs. I have led active pharmaceutical collaborations with global pharma and emerging biotech partners — serving as the primary scientific representative in technical due diligence, partnership evaluations, and executive stakeholder engagement. I have directly evaluated AI-enabled platforms, including foundation model and agentic AI approaches, for application to precision oncology decision-making.
I have authored 60+ peer-reviewed publications in Blood, Clinical Lung Cancer, Journal of Thoracic Oncology, and Journal of Neuro-Oncology, presented at AACR, ASCO, ASH, ESMO, and SITC, and hold 3 patents in oncology-focused computational methods.
Available to consult on: Oncology Biomarker Strategy • Patient Stratification & Target Engagement • Mechanism of Action & Resistance Analysis • NGS & Multi-Omics Data Interpretation • AI Model Evaluation for Life Sciences • Translational Research Design • Pharmaceutical Partnership Strategy • Precision Medicine Platform Review • Scientific Literature Review & Synthesis • Competitive Landscape Analysis in Oncology

専門分野

サービス

Writing

Writing Clinical Trial Documentation, Technical Writing

職務経験

Senior Director

Cellworks Research (India)

- 現在

学歴

M.SC Biotechnology

Thapar Institute of Engineering and Technology

7月 2005 - 6月 2007

認定資格

Drug Discovery

UC San Diego
https://coursera.org/share/a9b550284ead61ad962fea4ef0640a08
10月 2021 - 現在
Fundamentals of Immunology: Death by Friendly Fire

coursera
https://coursera.org/share/e1273e83716caf58f3c3d075d817864c
8月 2021 - 現在
Fundamentals of Immunology: Dueling with the Dark Side

coursera
https://coursera.org/share/9c9db354ebda64d272e914e7713c6331
8月 2021 - 現在
Fundamentals of Immunology Specialization

Rice University/Coursera
https://coursera.org/share/3938c0eb382c7b1ee62a3aaf38ea1f79
8月 2021 - 現在
Fundamentals of Immunology: T Cells and Signaling

Coursera/Rice University
https://coursera.org/share/2c9ba196fca4ac1a8b37579462b1076e
7月 2021 - 現在
Fundamentals of Immunology: Innate Immunity and B-Cell Function

Rice University/Coursera
https://coursera.org/share/7827a5c957d56984a3fa8022f419f60f
6月 2021 - 現在
Design and Interpretation of Clinical Trials

John Hopkins University/Coursera
https://coursera.org/share/6ceec50036be4b462f6da89abe65603b
5月 2021 - 現在
Understanding Clinical Research: Behind the Statistics

coursera
https://coursera.org/share/6ceec50036be4b462f6da89abe65603b
4月 2021 - 現在

出版物

JOURNAL ARTICLE

(2026). Comparison of liquid versus solid tissue genomic profiling for the prediction of chemo-immunotherapy benefit in advanced NSCLC . CANCER RESEARCH.

(2026). Computational modeling of comprehensive genomic profiling to predict chemo-immunotherapy benefit in early stage NSCLC . CANCER RESEARCH.

(2026). Entrepreneurship education, entrepreneurial competencies and entrepreneurial intentions: The moderating role of lecturer competency . INNOVATIONS IN EDUCATION AND TEACHING INTERNATIONAL.

(2026). Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors . CLINICAL LUNG CANCER.

(2025). Gender Identity and Mental Health Symptom Severity Among Adolescents Admitted to an Inpatient Psychiatric Hospital . CHILD PSYCHIATRY & HUMAN DEVELOPMENT.

(2025). Pilot study of an integrative telehealth group intervention for chronic pain . MEDICINE.

(2025). Therapeutic Alliance and Ruptures in Three Psychoanalytic Dyads: An Exploratory Investigation . PSYCHOANALYTIC INQUIRY.

(2025). Use of biosimulation to predict immune checkpoint inhibitor resistance in patients with high microsatellite instability . CANCER RESEARCH.

(2024). Opioid Risk Tool, in-hospital opioid exposure, and opioid demand predict pain outcomes following traumatic injury . JOURNAL OF HEALTH PSYCHOLOGY.

(2023). HPTLC profiling and hepatoprotective effect of Plumeria obtusa L. against CCl4 induced liver damage in rats . ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL.

(2022). Cellworks singula therapy response index (TRI) predicts clinical outcomes for esophageal adenocarcinoma: MyCare-004. JOURNAL OF CLINICAL ONCOLOGY.

(2022). Childhood Maltreatment, Impulsive Aggression, and Suicidality Among Patients Diagnosed With Bipolar Disorder . PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY.

(2022). Differentiation Scoring (DS) Derived from Cellworks Computational Omics Biology Model (CBM) Predicts Response to Hypomethylating Agents (HMA) and Patient Survival in Myelodysplastic Syndrome (MDS) . BLOOD.

(2022). Predictions of overall survival (OS) and progression-free survival (PFS) for specific therapeutic interventions in newly diagnosed glioblastoma multiforme (GBM) using Cellworks Singula: myCare-024-04. JOURNAL OF CLINICAL ONCOLOGY.

(2022). THE IMPACT OF MISMATCH REPAIR DEFICIENCY (MMRD) ON SURVIVAL OF TEMOZOLOMIDE (TMZ)-TREATED PATIENTS WITH MGMT METHYLATED (M-MGMT) GLIOBLASTOMA (GBM): A CELLWORKS COMPUTATIONAL BIOSIMULATION PILOT STUDY. NEURO-ONCOLOGY.

(2022). Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report . ANNALS OF TRANSLATIONAL MEDICINE.

(2022). Utility of a Brief Assessment of Opioid Demand Among Post-Discharge Trauma Care Patients . EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY.

(2021). Attachment Style Mediates the Relationship between Trauma and Somatic Distress among Individuals with Serious Mental Illness . PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES.

(2021). Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Identifies Genomic and Molecular Markers for Decitabine (DAC) Plus Valproic-Acid (VPA) Treatment Response in Patients with Myelodysplastic Syndromes (MDS) . BLOOD.

(2021). Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Identifies Immune Modulation As a Key Pathway for Predicting Azacitidine (AZA) Response in Myelodysplastic Syndromes (MDS) . BLOOD.

(2021). Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Predicted Novel Biomarkers for Hyper- CVAD (CVAD) Treatment Response and Combination of Rituximab and Cladribine (RC) in CVAD Resistant Cases of Mantle Cell Lymphoma (MCL) . BLOOD.

(2021). Biosimulation Using the Cellworks Computational Omics Biology Model (CBM)-Based Assessment of Cytarabine (ARA-C) and Anthracycline Response and Novel Biomarker Response Criteria for the Addition of Etoposide (VP16) in Acute Myeloid Leukemia (AML) . BLOOD.

(2021). Cellworks Omics Biology Model (CBM) to predict therapy response and identify biomarkers for all-trans retinoic acid (ATRA) benefit as addition to induction chemotherapy in adults with acute myeloid leukemia (AML) . JOURNAL OF CLINICAL ONCOLOGY.

(2021). Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit . JOURNAL OF NEURO-ONCOLOGY.

(2021). Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers . CELL DEATH DISCOVERY.

(2021). Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03 . JOURNAL OF CLINICAL ONCOLOGY.

(2021). Superior overall survival (OS), progression-free survival (PFS), and clinical response (CR) predictions for patients with non-small cell lung cancer (NSCLC) using Cellworks Singula: myCare-022-05 . JOURNAL OF CLINICAL ONCOLOGY.

(2021). Therapy Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Is Predictive of Individual Acute Myeloid Leukemia (AML) Patient Probability of Clinical Response (CR) and Overall Survival (OS): Mycare-023 . BLOOD.

(2020). Assessment of Cellworks Omics Biosimulation Therapy Response Predictions for Patients with Acute Myeloid Leukemia (AML) Using Cellworks Singula™: Mycare-020-01 . BLOOD.

(2020). Changes in Experimental Pain Sensitivity from Using Home-Based Remotely Supervised Transcranial Direct Current Stimulation in Older Adults with Knee Osteoarthritis . PAIN MEDICINE.

(2020). Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation-MyCare-015. JOURNAL OF CLINICAL ONCOLOGY.

(2020). Comparative Analysis for Differential Drug Response between Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) and T-Cell Acute Lymphoblastic Leukemia (T-ALL) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-03 . BLOOD.

(2020). Monosomy 7 and Co-Occurrent Genomic Aberrations Determine Chemotherapy Response in Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-04 . BLOOD.

(2020). Predicting Resistance to the Combination of ATO and ATRA in APL Patients with PML-Rara Fusions, Using a Computational Biology Modeling Approach: Mycare-021-01 . BLOOD.

(2020). Prediction of Clinical Response for Frontline Treatment of Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-02 . BLOOD.

(2020). Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02 . BLOOD.

(2020). Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01. JOURNAL OF CLINICAL ONCOLOGY.

(2020). Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03. JOURNAL OF CLINICAL ONCOLOGY.

(2020). Superior therapy response predictions for patients with low-grade glioma (LGG) using Cellworks Singula: MyCare-009-04. JOURNAL OF CLINICAL ONCOLOGY.

(2020). Superior therapy response predictions for patients with myelodysplastic syndrome (MDS) using Cellworks Singula: MyCare-009-02. JOURNAL OF CLINICAL ONCOLOGY.

(2020). Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05. JOURNAL OF CLINICAL ONCOLOGY.

(2020). The interactive effect of the serotonin transporter genotype and drug use on suicidal behaviors in patients diagnosed with bipolar disorder . JOURNAL OF AFFECTIVE DISORDERS.

(2019). Childhood Sexual Abuse and Suicidal Ideation Among Bipolar Patients: Existential But Not Religious Well-Being as a Protective Factor . SUICIDE AND LIFE-THREATENING BEHAVIOR.

(2018). Childhood Abuse, Intrapersonal Strength, and Suicide Resilience in African American Females who Attempted Suicide . JOURNAL OF FAMILY VIOLENCE.

(2018). Health Care Utilization for Chronic Pain in Low-Income Settings . PAIN MEDICINE.

(2018). Predicting Response to Dasatinib Using a Computational Model and Its Validation: A Beat AML Project Study . BLOOD.

(2018). Spiritual Openness, Revisiting a Potentially Important Aspect of Spirituality: Scale Review and Revision . JOURNAL OF RELIGION & HEALTH.

(2017). An Examination of Cultural Values and Pain Management in Foreign-Born Spanish-Speaking Hispanics Seeking Care at a Federally Qualified Health Center . PAIN MEDICINE.

(2017). Pain Catastrophizing, rather than Vital Signs, Associated with Pain Intensity in Patients Presenting to the Emergency Department for Pain . PAIN MANAGEMENT NURSING.

(2017). Perceived stress, depressive symptoms, and suicidal ideation in undergraduate women with varying levels of mindfulness . ARCHIVES OF WOMENS MENTAL HEALTH.

(2017). Predicting Response to CDK4/6 Inhibitors and Combinations Using a Computational Biology Model and Its Validation: A Beat AML Project Study. BLOOD.

(2017). The relationship of sociodemographic and psychological variables with chronic pain variables in a low-income population . PAIN.

(2016). Patients Presenting to the Emergency Department with Acute Pain: The Significant Role of Pain Catastrophizing and State Anxiety . PAIN MEDICINE.

(2015). Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide . ONCOTARGET.

(2015). Psychologists' Contributions to Patient-Centered Medical Homes . JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS.

(2014). In silico modeling predicts drug sensitivity of patient-derived cancer cells . JOURNAL OF TRANSLATIONAL MEDICINE.

(2014). A Novel and Personalized Method Using Simulation for Predicting Effective Therapeutics for Waldenstroms Macroglobulinemia . BLOOD.

(2014). Clinical translation pathway for identifying patient-specific dregs based on predictive simulation outcomes with ex vivo validation . JOURNAL OF CLINICAL ONCOLOGY.

(2014). Individualized therapy identified using simulation for bortezomib resistant patient with ex-vivo validation . CANCER RESEARCH.

(2014). Predicting GBM response to targeted therapeutics using simulation with ex vivo validations . JOURNAL OF CLINICAL ONCOLOGY.

(2014). Predictive Simulation Approach for Designing Cancer Therapeutic Regimens with Novel Biological Mechanisms . JOURNAL OF CANCER.

(2014). β-Caryophyllene Oxide Inhibits Constitutive and Inducible STAT3 Signaling Pathway Through Induction of the SHP-1 Protein Tyrosine Phosphatase . MOLECULAR CARCINOGENESIS.

(2013). Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3 . BRITISH JOURNAL OF PHARMACOLOGY.